Kite Pharma, Inc., based in Santa Monica, CA, specializes in the development of innovative chimeric antigen receptor (CAR) therapies for cancer treatment. The company focuses on harnessing the power of T cell therapy to enhance immune cell function, targeting specific antigens associated with various cancers, including prostate cancer. Kite Pharma's research encompasses advanced technologies such as modified receptors and antigen binding molecules, positioning the company at the forefront of immuno-oncology advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

51 Patents

#12 in Santa Monica, CA

#1,623 in California

#6,899 in US

#13,798 in the World

Santa Monica, CA, United States of America

Kite Pharma, Inc.

Forward Citations = 93

62 inventors:

Stuart A Sievers (15 out of 17 patents)

Adrian I Bot (11 out of 11 patents)

Jed Wiltzius (11 out of 12 patents)

4. Jed J W Wiltzius (7 out of 7 patents)

5. Steven A Rosenberg (6 out of 150 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kite Pharma, Inc.. Retrieved from https://idiyas.com/company/kite-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

12 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]